Skip to content

Measuring Corneal Cells With Specular Microscopy

Specular Photomicrograpic Assessment of the Effect of Anti-VEGF Intravitreal Injections on Corneal Thickness and Endothelial Cell Density and Morphology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01792154
Enrollment
30
Registered
2013-02-15
Start date
2012-08-31
Completion date
2012-11-30
Last updated
2013-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Diseases

Brief summary

Assess changes in the corneal cell count using Specular Microscopy following tretments with Anti-VEGF injections

Detailed description

Patients with active Wet AMD often receive intraocular Anti-VEGF injections such as Macugen, Lucentis and Avastin on a monthly basis for an extended period of time. While these medications are very effective at controlling the Choroidal Neovascularization associated with this disease, the impact of monthly intravigtreal Anti-VEGF injections on the viability of corneal endothelial cells has yet to be fully characterized. The availability of CESM as a diagnostic test that can be performed quickly and painlessly in the clinic offers a method of tracking corneal endothelial cell count in this patient population.

Interventions

None listed

Sponsors

Retina Institute of Hawaii
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Wet Age-related Macular Degeneration * Receiving monthly intraocular injections of Anti-VEGF medication for at least 3 months * Age greater than 50 years of age

Exclusion criteria

* experiences adverse events

Design outcomes

Primary

MeasureTime frameDescription
Specular Photomicrographic Assessment of the Effect of Anti-VEGF Intravitreal injections on corneal thickness and endothelial cell density and morphologyBaseline, Month 6 and Month 12Changes in corneal endothelial cell density and corneal thickness measured by changes in pachymetry and corneal cell count.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026